Pretoria – After encouraging results on a vaginal gel containing the antiretroviral drug tenofovir, which reduces HIV infection and risk of contracting genital herpes, a follow-up study to test the safety of the gel has been launched. The Phase III trial, to be known as FACTS 001, will be conducted by the Follow-on African Consortium [...]
New test phase of HIV gel launched is a post from: GlobalBuzz SA
